The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Ignore sienna absolutely delusional. Has £100 of share as said previously.
Not investors basically fools gambling - have no understanding And do zero research what so ever.
Utter madness.
Must be sitting on losses across all
Shares - Ah well….
This will be getting sold into for years now.
topped up also
Signed already as per previous RNS.
Yawn.
Dear dear me - very naive.
I’m not leading horses to water - you could Google yourself in minutes and would prevent you posting and wasting energy and sheer and utter garbage.
Good luck.
You probably also need to google valuations on medical devices, Apps, tools of similar ilk
GL in your research
If I make a device to go in a plane I make a device
This is fun.
VAL were going to go bust until share holders ousted the BOD - aka George Morris.
Prostate cancer dosing application is a medical device
Really really really?
Think you need to do alittle more homework and not Manipulate peoples opinions based on information
That’s clearly incorrect and you know it. (Read more)
It’s easy to say MC is less than an all time high - let’s pick Amazon, Google, or anything in fact yeah !!!
£20 millions where’s that from ? The purchase price of a company before they rolled the product out to 1000’s of medical centres and hospitals globally including Portugals health service - yeah nice one (laughing emoji)
No clear cut product haaa ok then do you have a medical background on the time it takes for medical devices to come to market . Emoji you pick one pretty sure the ICR and CRUK are supportive Ah well your opinion is key.
You haven’t mentioned the VAL payment of £6million on completion of there deal. Why not? Or Bicycle or Merck or Astellas or Tabula or Cellcentric or Lilly ???
Guess you would rather sit on and oil company which is chucking millions a day at nothing or maybe something???
Good luck
Changed the subject ?
See previous post reference commercial revenue generating deal which can be utilised globaly.
Growth Stock...
Not a straight answer ok. I just believe people should do research without being spoon fed.
Anyway for your benefit,
Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, announces today it has entered into a partnership with Physiomics plc (AIM: PYC), the oncology consultancy using mathematical models to support the development of cancer treatment regimens and personalized medicine solutions. Through this initiative, Physiomics’ personalized docetaxel model will be integrated into TRHC’s market-leading precision dosing solution, DoseMeRx®. Both parties expect positive feedback from this initial trial with the next step being a commercial agreement.
DosemeRX as per RNS
The prostate cancer dosing application that is currently in trials to over 70 patients.
These things take years to develop- this is the answer to your question as this tech will save millions and is on the verge of signing revenue generating deal will will be realised on a monthly basis
Personally I’d expect some news pre interims IMO
History would say so…
Some news surely needs to be due and BIG as this is slowing bleeding to death
Email JM he will respond.
what email you trying?
Has anyone emails Suzi?
The fact you have held for x amount of time and sold literally just below the news flow and updates.
Absolutely screams someone who have very little understand if the business or the industry which it is in.
Not enough research or dialog with the company I guess.
Therefore I was merely stating good as laziness shouldn’t be rewarded.
GL anyway